Ethical challenges of prospective clinical trials during the COVID-19 pandemic

References

• Rubin EJ, Baden LR, Morrissey S. Audio interview: looking back and looking forward — part 1. N Engl J Med. 2021 Jul 29;385(5):e24.
   PubMed Web of Science ®Google Scholar
• Rubin EJ, Baden LR, Armstrong KA, et al. Audio interview: the impact of Covid-19 on trainees and junior faculty. N Engl J Med. 2021 September 22;385(4):e21.
   PubMed Web of Science ®Google Scholar
• Staff A. A Timeline of COVID-19 Developments of COVID-19. Cranbury (NJ): American Journal of Managed Care; 2021.
   Google Scholar
• Administration USFaD. FDA guidance on conduct of clinical trials of medical products during the COVID-19 public health emergency. 2020.
   Google Scholar
• Lawler PR, Goligher EC, and Berger JS, et al. Therapeutic anticoagulation with heparin in noncritically Ill patients with Covid-19. N Engl J Med. 2021 Aug 04;31:1161-1169.
   Web of Science ®Google Scholar
• Ten Cate H. Surviving Covid-19 with Heparin? N Engl J Med. 2021 Aug 04;385:845–846.
   PubMed Web of Science ®Google Scholar
• University S. Medical Ethics 101. Stanford (CA): Stanford University; 2014.
   Google Scholar
• Jahn WT. The 4 basic ethical principles that apply to forensic activities are respect for autonomy, beneficence, nonmaleficence, and justice. J Chiropr Med. 2011 Sep;10(3):225–226.
   PubMedGoogle Scholar
• Woods P, Flynn M, Monach P, et al. Implementation of documented and written informed consent for clinical trials of communicable diseases: lessons learned, barriers, solutions, future directions identified during the conduct of a COVID-19 clinical trial. Contemp Clin Trials Commun. 2021 Sep 23;23:100804.
   PubMed Web of Science ®Google Scholar
• Lurie N, Sharfstein JM, Goodman JL. The development of COVID-19 vaccines: safeguards needed. JAMA. 2020 Aug 04;324(5):439–440.
   PubMed Web of Science ®Google Scholar
• Raturi M, Kala M, Das K, et al. Reviewing the ethical concerns of the convalescent plasma therapy in COVID-19. J Lab Physicians. 2021 Mar;13(1):91–94.
   PubMed Web of Science ®Google Scholar
• Guharoy R, and Krenzelok EP. FDA emergency use authorization: glass half empty? Clin Infect Dis. 2020 Oct;16:898-899.
   Web of Science ®Google Scholar
• Melillo G. FDA grants emergency use authorization for COVID-19 Treatment. Cranbury (NJ): American Journal of Managed Care; 2020.
   Google Scholar
• Wang Y, Zhang D, Du G, et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020 May 16;395(10236):1569–1578.
   PubMed Web of Science ®Google Scholar
• Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the treatment of Covid-19 - Final report. N Engl J Med. 2020 November 05;383(19):1813–1826.
   PubMed Web of Science ®Google Scholar
• Rubin D, Chan-Tack K, Farley J, et al. FDA Approval of Remdesivir - A Step in the Right Direction. N Engl J Med. 2020 Dec 31;383(27):2598–2600.
   PubMed Web of Science ®Google Scholar
• O’Brien MP, Forleo-Neto E, and Musser BJ, et al. Subcutaneous REGEN-COV antibody combination for Covid-19 prevention. medRxiv. 2021 Jun 17;33:1947-1959.
   Google Scholar
• Administration UFaD. Fact Sheet for Health Care Providers Emergency Use Authorization (EUA) of REGEN-COV (casarivimab and imdevimab). Rev ed. Silver Spring (MD): US Food and Drug Administration; 2021.
   Google Scholar
• Administration UFaD. FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems. Silver Spring (MD): US Food and Drug Administration; 2020.
   Google Scholar
• Naksuk N, Lazar S, Peeraphatdit TB. Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol. Eur Heart J Acute Cardiovasc Care. 2020Apr9;9(3):215–221.
   PubMed Web of Science ®Google Scholar
• Burrell ZL, Martinez AC. Chloroquine and hydroxychloroquine in the treatment of cardiac arrhythmias. N Engl J Med. 1958 Apr 17;258(16):798–800.
   PubMed Web of Science ®Google Scholar
• Ac K. Treating COVID-19-off-label drug use, compassionate use, and randomized clinical trials during pandemics. JAMA. 2020 May 19;323(19):1897–1898.
   PubMed Web of Science ®Google Scholar
• Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020 May;20(5):533–534.
   PubMed Web of Science ®Google Scholar
• Aquino YSJ, Cabrera N. Hydroxychloroquine and COVID-19: critiquing the impact of disease public profile on policy and clinical decision-making. J Med Ethics. 2020 09;46(9):574–578.
   PubMed Web of Science ®Google Scholar
• Blevins JL, Edgerton E, Don P. Shouting into the wind: medical science versus “B.S.” in the twitter maelstrom of politics and misinformation about hydroxychloroquine. Soc Media + Soc. 2021;7(2):20563051211024977.
   Web of Science ®Google Scholar
• Di Pasquale G, Maggioni AP, Gervasoni C, et al. Trials and tribulations of coronavirus disease-2019 research: with a few bright lights in the fog. J Cardiovasc Med (Hagerstown). 2020 Nov;21(11):841–844.
   PubMed Web of Science ®Google Scholar
• Hashmi SK, De Vol E, Hussain F. Pride and prejudice during the COVID-19 pandemic: the misfortune of inappropriate clinical trial design. J Epidemiol Glob Health. 2021 March;11(1):15–19.
   PubMed Web of Science ®Google Scholar
• Saag MS. Misguided use of hydroxychloroquine for COVID-19: the infusion of politics into science. JAMA. 2020 December 01;324(21):2161–2162.
   PubMed Web of Science ®Google Scholar
• Self WH, Semler MW, Leither LM, et al. Effect of hydroxychloroquine on clinical status at 14 days in hospitalized patients with COVID-19: a randomized clinical trial. JAMA. 2020 December 01;324(21):2165–2176.
   PubMed Web of Science ®Google Scholar
• Schrezenmeier E, Dörner T. Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat Rev Rheumatol. 2020 March;16(3):155–166.
   PubMed Web of Science ®Google Scholar
• Borba MGS, Val FFA, Sampaio VS, et al. Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial. JAMA Network Open. 2020 April 24;3(4):e208857.
   PubMed Web of Science ®Google Scholar
• Emani VR, Goswami S, Nandanoor D, et al. Randomised controlled trials for COVID-19: evaluation of optimal randomisation methodologies-need for data validation of the completed trials and to improve ongoing and future randomised trial designs. Int J Antimicrob Agents. 2021 Jan;57(1):106222.
   PubMed Web of Science ®Google Scholar
• Lacout A, Perronne C, Lounnas V. Hydroxychloroquine in hospitalized patients with covid-19. N Engl J Med. 2021 March 04;384(9):881–882.
   PubMed Web of Science ®Google Scholar
• Mitjà O, Corbacho-Monné M, Ubals M, et al. A cluster-randomized trial of hydroxychloroquine for prevention of Covid-19. N Engl J Med. 2021 February 04;384(5):417–427.
   PubMed Web of Science ®Google Scholar
• Pan H, Peto R, Henao-Restrepo AM, et al. Repurposed antiviral drugs for Covid-19 - Interim WHO solidarity trial results. N Engl J Med. 2021 February 11;384(6):497–511.
   PubMed Web of Science ®Google Scholar
• Ben-Zvi I, Kivity S, Langevitz P, et al. Hydroxychloroquine: from malaria to autoimmunity. Clin Rev Allergy Immunol. 2012 Apr;42(2):145–153.
   PubMed Web of Science ®Google Scholar
• Ghazy RM, Almaghraby A, Shaaban R, et al. A systematic review and meta-analysis on chloroquine and hydroxychloroquine as monotherapy or combined with azithromycin in COVID-19 treatment. Sci Rep. 2020 December 17;10(1):22139.
   PubMed Web of Science ®Google Scholar
• Liu J, Cao R, Xu M, et al. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discov. 2020 Mar 18;6(1):16.
   PubMed Web of Science ®Google Scholar
• Savarino A, Boelaert JR, Cassone A, et al. Effects of chloroquine on viral infections: an old drug against today’s diseases? Lancet Infect Dis. 2003 Nov;3(11):722–727.
   PubMed Web of Science ®Google Scholar
• Savarino A, Di Trani L, Donatelli I, et al. New insights into the antiviral effects of chloroquine. Lancet Infect Dis. 2006 Feb;6(2):67–69.
   PubMed Web of Science ®Google Scholar
• Keyaerts E, Vijgen L, Maes P, et al. In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine. Biochem Biophys Res Commun. 2004 Oct 08;323(1):264–268.
   PubMed Web of Science ®Google Scholar
• Vincent MJ, Bergeron E, Benjannet S, et al. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J. 2005 Aug;22(2):69.
   Web of Science ®Google Scholar
• Wang YY, Huang Q, Shen Q, et al. Quality of and recommendations for relevant clinical practice guidelines for COVID-19 management: a systematic review and critical appraisal. Front Med (Lausanne). 2021;8:630765.
   PubMed Web of Science ®Google Scholar
• Wang M, Cao R, Zhang L, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020 03; 30(3): 269–271.
   PubMed Web of Science ®Google Scholar
• Yao X, Ye F, Zhang M, et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020 September 28;71(15):732–739.
   PubMed Web of Science ®Google Scholar
• Glasziou PP, Sanders S, Hoffmann T. Waste in covid-19 research. BMJ. 2020 May;12(369):m1847.
   Google Scholar
• Mehra MR, Ruschitzka F, Patel AN, Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19. a multinational registry analysis. Lancet. 2020;395(10240):1820.
   PubMed Web of Science ®Google Scholar
• Rabin RC, Gabler E. Two huge COVID-19 studies are retracted after scientists sound alarms. New York Times; 2020.
   Google Scholar
• Bierer BE, White SA, Barnes JM, et al. Ethical challenges in clinical research during the COVID-19 Pandemic. J Bioeth Inq. 2020 Dec;17(4):717–722.
   PubMed Web of Science ®Google Scholar
• Pang W, Wang Q, Zhao Z. Development and progress of clinical trials of Coronavirus disease 2019 antiviral drugs. Expert Rev Clin Pharmacol. 2020 Sep;13(9):945–956.
   PubMed Web of Science ®Google Scholar
• Evans SR. Clinical trial structures. J Exp Stroke Transl Med. 2010 Feb 09; 3(1):8–18.
   PubMedGoogle Scholar
• Kendall JM. Designing a research project: randomised controlled trials and their principles. Emerg Med J. 2003 Mar;20(2):164–168.
   PubMed Web of Science ®Google Scholar
• Hulley SB. Designing clinical research. 4th ed. Philadelphia. Philadelphia, Pennsylvania: Wolters Kluwer/Lippincott Williams & Wilkins; 2013.
   Google Scholar
• Nguyen T, Duong Bang D, Wolff A. Novel Coronavirus disease (COVID-19): paving the Road for Rapid Detection and Point-of-Care Diagnostics. Micromachines (Basel). 2019 [2020 Mar]; 11(3). https://doi.org/10.3390/mi11030306.
   Google Scholar
• Association AM. Code of medical ethics opinion 1. 2.11. Ethically Sound Innovation in Medical Practice: American Medical Association.
   Google Scholar
• Ea L, Fg M, Pearson SD. Going off-label without venturing off-course: evidence and ethical off-label prescribing. Arch Intern Med. 2009 Oct 26;169(19):1745–1747.
   PubMedGoogle Scholar
• Richesson RL. Learning health systems, embedded research, and data standards-recommendations for healthcare system leaders. JAMIA Open. 2020 Dec;3(4):488–491.
   PubMedGoogle Scholar
• Lin SY, Schneider CE, and Bristol AA, et al. Sequential pilot Trials of Aliviado Dementia Care to Inform an Embedded Pragmatic Clinical Trial. Gerontologist. 2020 Dec;23:30.
   Web of Science ®Google Scholar
• Mitchell SL, Mor V, Harrison J, et al. Embedded pragmatic trials in dementia care: realizing the vision of the NIA IMPACT collaboratory. J Am Geriatr Soc. 2020 07; 68(Suppl 2): S1–S7.
   PubMed Web of Science ®Google Scholar
• Radford KA, Craven K, McLellan V, et al. An individually randomised controlled multi-centre pragmatic trial with embedded economic and process evaluations of early vocational rehabilitation compared with usual care for stroke survivors: study protocol for the RETurn to work After stroKE (RETAKE) trial. Trials. 2020 Dec 09;21(1):1010.
   PubMed Web of Science ®Google Scholar
• Brody AA, Barnes DE, Chodosh J, et al. Building a national program for pilot studies of embedded pragmatic clinical trials in dementia care. J Am Geriatr Soc. 2020 07;68(Suppl 2):S14–S20.
   PubMed Web of Science ®Google Scholar
• George SZ, Coffman CJ, Allen KD, et al. Improving veteran access to integrated management of back pain (AIM-Back): protocol for an embedded pragmatic cluster-randomized trial. Pain Med. 2020 December 12;21(Suppl 2):S62–S72.
   PubMed Web of Science ®Google Scholar
• Platt R, Simon GE, Hernandez AF. Is learning worth the trouble? - Improving health care system participation in embedded research. N Engl J Med. 2021Jul01;385(1):5–7.
   PubMed Web of Science ®Google Scholar